Cargando…

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?

Diabetes mellitus is a pandemic metabolic disorder that results from either the autoimmune destruction or the dysfunction of insulin-producing pancreatic beta cells. A promising cure is beta cell replacement through the transplantation of islets of Langerhans. However, donor shortage hinders the wid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeois, Stephanie, Sawatani, Toshiaki, Van Mulders, Annelore, De Leu, Nico, Heremans, Yves, Heimberg, Harry, Cnop, Miriam, Staels, Willem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835995/ https://www.ncbi.nlm.nih.gov/pubmed/33477961 http://dx.doi.org/10.3390/cells10010191

Ejemplares similares

Semi-automated digital measurement as the method of choice for beta cell mass analysis
por: Coppens, Violette, et al.
Publicado: (2018)

The zinc finger transcription factor PW1/PEG3 restrains murine beta cell cycling
por: Sojoodi, Mozhdeh, et al.
Publicado: (2016)

Generation of Functional Beta-Like Cells from Human Exocrine Pancreas
por: Lima, Maria J., et al.
Publicado: (2016)

Epigenetic aspects of pancreatic beta cell function in type 2 diabetes
por: Cnop, Miriam
Publicado: (2014)

Mining the transcriptome of target tissues of autoimmune and degenerative pancreatic β-cell and brain diseases to discover therapies
por: Yi, Xiaoyan, et al.
Publicado: (2022)

In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo
por: Fantuzzi, Federica, et al.
Publicado: (2022)

STAT3 modulates β-cell cycling in injured mouse pancreas and protects against DNA damage
por: De Groef, S, et al.
Publicado: (2016)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3
por: Heremans, Yves, et al.
Publicado: (2002)

Cell-Based Therapies for Stroke: Are We There Yet?
por: Krause, Mirja, et al.
Publicado: (2019)

Biomarkers in renal cell carcinoma: Are we there yet?
por: Gulati, Shuchi, et al.
Publicado: (2021)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Beta Cells within Single Human Islets Originate from Multiple Progenitors
por: Scharfmann, Raphaël, et al.
Publicado: (2008)

Conditional Hypovascularization and Hypoxia in Islets Do Not Overtly Influence Adult β-Cell Mass or Function
por: D'Hoker, Joke, et al.
Publicado: (2013)

Stem-cell therapy for hearing loss: are we there yet?()
por: Dufner-Almeida, Luiz Gustavo, et al.
Publicado: (2019)

Reprogramming of human pancreatic exocrine cells to β-like cells
por: Lemper, M, et al.
Publicado: (2015)

Humanized mice: are we there yet?
por: Macchiarini, Francesca, et al.
Publicado: (2005)

Cancer vaccines: Are we there yet?
por: Hanna, Jr., Michael G.
Publicado: (2012)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Myocardial Inflammation—Are We There Yet?
por: Greulich, Simon, et al.
Publicado: (2015)

The Artificial Pancreas: Are We There Yet?
por: Cefalu, William T., et al.
Publicado: (2014)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Peak MSC—Are We There Yet?
por: Olsen, Timothy R., et al.
Publicado: (2018)

Dracunculiasis Eradication: Are We There Yet?
por: Hopkins, Donald R., et al.
Publicado: (2018)

Robotics and ophthalmology: Are we there yet?
por: Pandey, Suresh K, et al.
Publicado: (2019)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Biomarkers for SUDEP: Are We There Yet?
por: King-Stephens, David
Publicado: (2019)

Safe Nanoparticles: Are We There Yet?
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020)

Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2011)

Automatic Coding of Facial Expressions of Pain: Are We There Yet?
por: Lautenbacher, Stefan, et al.
Publicado: (2022)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes
por: Hajizadeh-Saffar, E., et al.
Publicado: (2015)

EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion
por: Blanchi, Bruno, et al.
Publicado: (2023)

Prion propagation in vitro: are we there yet?
por: Ryou, Chongsuk, et al.
Publicado: (2008)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ve6lcqnslnvavv6dmlkclmk77